Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Adamas Pharmaceuticals Inc (ADMS) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/24/2021 4 BIGHAM MICHAEL (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Unknown transaction of 10,000 shares @ $0
Disposed/sold 10,000 options to buy @ $4.8, valued at $48k
Disposed/sold 10,000 options to buy @ $2.7, valued at $27k
Disposed/sold 10,000 options to buy @ $5.21, valued at $52.1k
11/24/2021 4 MAHONEY DAVID L (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Unknown transaction of 5,000 shares @ $0
Unknown transaction of 112,781 shares @ $0
Disposed/sold 10,000 options to buy @ $4.8, valued at $48k
Disposed/sold 40,000 options to buy @ $6.08, valued at $243.2k
Disposed/sold 10,000 options to buy @ $2.7, valued at $27k
Disposed/sold 10,000 options to buy @ $5.21, valued at $52.1k
11/24/2021 4 McFarlane Neil F. (CEO) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Granted 75,000 shares @ $0
Unknown transaction of 600,000 shares @ $0
Disposed/sold 250,000 options to buy @ $6.25, valued at $1.6M
Disposed/sold 200,000 options to buy @ $1.99, valued at $398k
11/24/2021 4 Prentiss Christopher B (CFO) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Granted 18,750 shares @ $0
Unknown transaction of 163,767 shares @ $0
Disposed/sold 37,500 options to buy @ $6.81, valued at $255.4k
Disposed/sold 50,000 options to buy @ $4.7, valued at $235k
11/24/2021 4 Ericson William W. (10% Owner) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Unknown transaction of 10,000 shares @ $0
Unknown transaction of 4,031,804 shares @ $0
Unknown transaction of 6,043 shares @ $0
Unknown transaction of 3,146 shares @ $0
Unknown transaction of 25,661 shares @ $0
Unknown transaction of 287,992 shares @ $0
Unknown transaction of 265,150 shares @ $0
Disposed/sold 10,000 options to buy @ $4.8, valued at $48k
Disposed/sold 10,000 options to buy @ $2.7, valued at $27k
Disposed/sold 10,000 options to buy @ $5.21, valued at $52.1k
11/24/2021 4 Shreedhar Vijay (Chief Commercial Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Granted 18,750 shares @ $0
Unknown transaction of 186,786 shares @ $0
Disposed/sold 137,500 options to buy @ $4.67, valued at $642.1k
Disposed/sold 47,500 options to buy @ $2.32, valued at $110.2k
11/24/2021 4 Papapetropoulos Spyridon (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Unknown transaction of 20,975 shares @ $0
Disposed/sold 20,000 options to buy @ $4.35, valued at $87k
Disposed/sold 10,000 options to buy @ $5.21, valued at $52.1k
11/24/2021 4 RICHO ANNA (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Unknown transaction of 25,000 shares @ $0
Disposed/sold 20,000 options to buy @ $5.12, valued at $102.4k
Disposed/sold 10,000 options to buy @ $5.21, valued at $52.1k
11/24/2021 4 DEMSKI MARTHA J (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Unknown transaction of 16,000 shares @ $0
Unknown transaction of 5,000 shares @ $0
Disposed/sold 10,000 options to buy @ $4.8, valued at $48k
Disposed/sold 10,000 options to buy @ $2.7, valued at $27k
Disposed/sold 10,000 options to buy @ $5.21, valued at $52.1k
11/24/2021 4 MacPhee John A (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Unknown transaction of 202,000 shares @ $0
Disposed/sold 24,000 options to buy @ $3.305, valued at $79.3k
Disposed/sold 10,000 options to buy @ $4.8, valued at $48k
Disposed/sold 10,000 options to buy @ $2.7, valued at $27k
Disposed/sold 10,000 options to buy @ $5.21, valued at $52.1k
06/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2021 4 DEMSKI MARTHA J (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Sold 2,000 shares @ $5.17, valued at $10.3k
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2021 4 Papapetropoulos Spyridon (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Granted 5,000 shares @ $0
Granted 10,000 options to buy @ $5.21, valued at $52.1k
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2021 4 DEMSKI MARTHA J (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Granted 5,000 shares @ $0
Granted 10,000 options to buy @ $5.21, valued at $52.1k
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/23/2021 4 Prentiss Christopher B (CFO) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Sold 2,422 shares @ $5.48, valued at $13.3k
03/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/15/2021 4 Papapetropoulos Spyridon (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Bought 5,975 shares @ $5.06, valued at $30.2k
03/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2021 4 Prentiss Christopher B (CFO) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Sold 3,821 shares @ $6.36, valued at $24.3k
02/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/22/2021 4 Prentiss Christopher B (CFO) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Sold 2,630 shares @ $4.41, valued at $11.6k
11/24/2020 4 Papapetropoulos Spyridon (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Granted 10,000 shares @ $0
Granted 20,000 options to buy @ $4.35, valued at $87k
11/24/2020 3 Papapetropoulos Spyridon (Director) has filed a Form 3 on Adamas Pharmaceuticals Inc
11/02/2020 4 Prentiss Christopher B (CFO) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Sold 2,050 shares @ $3.21, valued at $6.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy